Oppenheimer analyst Ed Yang raised the price target on KLA Corporation (NASDAQ: KLAC) to $1,800.00 (from $1,400.00) while maintaining an Outperform rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+17% KLAC $168.47 → $196.83 (Oct 8) · 2% of the way to the target

This call at 6 months✓ Target reached on Apr 20, 2026, 3 months after the note. Prices are split-adjusted.

Firm track recordOppenheimer reached 73% of its 11 scored targets within six months (#12 of 31 firms). Accuracy ranking →

Earnings reactionOne of 10 notes after KLA’s Jan 29 results: 10 of 10 raised targets. See every call →
Oppenheimer on KLA · target history
Jan 30, 2026 · $1,800 · Buy · this note Mar 11, 2026 · $1,800 · Buy Apr 30, 2026 · $2,000 · Buy Jul 16, 2026 · $2,600 · Buy

Targets are adjusted for the 10-for-1 split on Jun 12, 2026, so every call is in the same share terms as this note.

Share

More from Oppenheimer on KLA

Jul 16, 2026 Buy Raised price target +30%, kept rating $260from $200

Other KLA notes

Morgan StanleyBuy Cut price target −10%, kept rating · Oct 6 $227from $253 UBSHold Cut price target −7%, kept rating · Sep 1 $200from $215 BernsteinBuy Raised price target +11%, kept rating · Aug 10 $250from $225 StifelBuy Cut price target −7%, kept rating · Jul 29 $250from $270 CantorBuy Kept rating and price target · Jul 29 $325maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.